Global Injectable Drug Delivery Market (2010 - 2015)

03 Jun 2011 • by Natalie Aster

WilmingtonRapid enhancements in drug discovery technologies leading to developments in proteomics and genomics have essentially had a greater impact on injectable drug delivery market. The number of injectable drugs to be introduced in medium to long term future is expected to be significant, to outweigh the threat from advanced alternative drug delivery technologies. Additionally increasing innovation in alternative technologies has extended the focus of injectable market participants on issues such injector design, convenience and painless modes of injectables and customization. The aligned pharmaceutical industries are actively collaborating with drug delivery companies to effectively target the patient concerns. Such strategic issues are driving the market significantly. The changing market trends, compels the industry participants to have extended clarity on market dynamics, increasing innovation from alternative technologies and threat from competitors in injectable drug delivery market to sustain their market position.

The report “Global Injectable Drug Delivery Market (2010 - 2015)” by MarketsandMarkets highlights the global injectable drug delivery market segmented as below:

  • Injectable systems (Sustained Release Injectable Systems, Needleless Systems Microneedle Injectors, Liposomal Systems/ PEGylation, Novel Injectable Technologies);
  • By mode of drug delivery (Intradermal, Subcutaneous, Intramuscular, Intravenous, Intraosseous, intraperitoneal);
  • By Therapeutics (Diabetes, Hepatitis C, Oncology, Rheumatoid Arthritis etc);
  • By Reusability (Reusable, Disposable, Pre-filled, Custom);
  • By Drug Classes (Antimuscarinics, Cytokines, Dopamine, Hematopoietics, Human Growth Hormone etc).

Report Details:

Global Injectable Drug Delivery Market (2010 - 2015)

Published: February 2011

Pages: 253

Price: US$ 4,650.00

Report Sample Abstract


In a non-competitive market where no similar drug is available a company may choose to launch a drug in simple administration form in the initial stage. However, once the drug reaches patent expiry the same drug may be launched with certain unique qualities such as special form of administration.


For example, interferon alfa, which is one of the well-known and prevalent therapy for treatment of hepatitis-C was earlier launched in the vials either in liquid or lyophilized form. However, with increasing competition several product improvements were launched in the form of prefilled syringes for the liquid formulations and multi dose pen injectors for lyophilized formulations.


Nano sized drug delivery technologies are primarily used as a mode to achieve sustained release of any drug into the body. Apart from this small size of liposomal systems, polymeric micelles and microspheres enable easy penetration into the cell. This characteristic has been primarily used to improve dissolution and solubility characteristics of water insoluble drugs.

From the application side, the market for drug delivery formulation technologies is driven by increasing need for sustained release and drug delivery in wide range of application areas. The oncology therapeutics segment forms the largest share of the nano-enabled drug delivery systems. This is followed by CNS drugs, anti-infective and anti-inflammatory drugs. The cardio vascular therapeutics segment forms the smallest segment of the market.

More information can be found in the report “Global Injectable Drug Delivery Market (2010 - 2015)” by MarketsandMarkets.

To order the report or ask for sample pages contact



MarketPublishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970